Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewAtom Labs is an active, India-based CDMO specializing in the development, scale-up, and manufacturing of novel and complex drug substances for pharmaceutical, biotech, and chemical companies. The company emphasizes innovative chemistry platforms such as flow chemistry, bio-catalysis, carbohydrates, chiral chemistry, green chemistry techniques for sustainability, and leverages digital technologies like AI/VR to enhance efficiency. Their facilities are US FDA and EU GMP audited.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewAtom Labs.